IL-6 Inhibition as a Treatment for Noninfectious Uveitis

• by Naveen Karthik, MD, Dilraj S. Grewal, MD, FASRS

• September 1, 2025

Vamikibart Shows Early Safety in Uveitic Macular Edema

Phase 1 nonrandomized trial reported no drug-related serious adverse events, but efficacy remains unproven

• by Kerri Miller

• May 7, 2026

• 3 min

Things You Didn’t Know About SLT

Experienced surgeons dispel myths about selective laser trabeculoplasty and provide pearls and practice insights.

• by Syril K. Dorairaj, MD, and, Ariana Levin, MD, Tony Realini, MD, MPH, Constance O. Okeke, MD, MSCE, Steven R. Sarkisian, Jr., MD, Christine Funke, MD, Lorraine M. Provencher, MD, Marlene R. Moster, MD, Shivani S. Kamat, MD, Sahar Bedrood, MD, PhD, Douglas J. Rhee, MD, Jacob W. Brubaker, MD, Kateki Vinod, MD, Lauren S. Blieden, MD, Mary Qiu, MD,, Samantha Goldburg, MD, John Berdahl, MD

• March 1, 2026

• 18 min

Clinical Features and Prognostic Outcomes in Patients with Ocular Syphilis and HIV Co-Infection

• by Wenjun Kong, Fang Ruan, Lianyong Xie, Xia Feng, Yanqing Gao, Zhuyun Qian, Yong Tao

• November 19, 2025